- Home
- ESPR vs MBCN Comparison
ESPR vs MBCN Comparison
Compare ESPR & MBCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- MBCN
- Stock Information
- Founded
- ESPR 2008
- MBCN 1901
- Country
- ESPR United States
- MBCN United States
- Employees
- ESPR N/A
- MBCN N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- MBCN Major Banks
- Sector
- ESPR Health Care
- MBCN Finance
- Exchange
- ESPR Nasdaq
- MBCN Nasdaq
- Market Cap
- ESPR 208.1M
- MBCN 234.0M
- IPO Year
- ESPR 2013
- MBCN N/A
- Fundamental
- Price
- ESPR $0.85
- MBCN $29.35
- Analyst Decision
- ESPR Buy
- MBCN Hold
- Analyst Count
- ESPR 7
- MBCN 1
- Target Price
- ESPR $5.93
- MBCN $32.00
- AVG Volume (30 Days)
- ESPR 6.2M
- MBCN 8.6K
- Earning Date
- ESPR 05-06-2025
- MBCN 07-17-2025
- Dividend Yield
- ESPR N/A
- MBCN 2.86%
- EPS Growth
- ESPR N/A
- MBCN N/A
- EPS
- ESPR N/A
- MBCN 2.00
- Revenue
- ESPR $259,574,000.00
- MBCN $66,931,000.00
- Revenue This Year
- ESPR $4.07
- MBCN $15.08
- Revenue Next Year
- ESPR N/A
- MBCN $5.02
- P/E Ratio
- ESPR N/A
- MBCN $14.64
- Revenue Growth
- ESPR 12.99
- MBCN N/A
- 52 Week Low
- ESPR $0.69
- MBCN $20.61
- 52 Week High
- ESPR $3.94
- MBCN $34.00
- Technical
- Relative Strength Index (RSI)
- ESPR 44.65
- MBCN 57.30
- Support Level
- ESPR $0.79
- MBCN $28.66
- Resistance Level
- ESPR $0.88
- MBCN $29.70
- Average True Range (ATR)
- ESPR 0.07
- MBCN 0.63
- MACD
- ESPR 0.02
- MBCN -0.10
- Stochastic Oscillator
- ESPR 69.48
- MBCN 67.65
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About MBCN Middlefield Banc Corp.
Middlefield Banc Corp is a bank holding company. It offers customers, banking services including checking, savings, negotiable order of withdrawal (NOW) accounts, money market accounts, time deposits, commercial loans, real estate loans, a variety of consumer loans, safe deposit facilities, and travelers' checks. It also provides online banking and bill payment services to individuals and online cash management services to business customers.